XML 100 R76.htm IDEA: XBRL DOCUMENT v3.6.0.2
Segment and Geographical Area Information - General (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Segment and Geographical Area Information                      
Net Sales to External Customers $ 5,333 $ 5,302 $ 5,333 $ 4,885 $ 5,188 $ 5,150 $ 5,170 $ 4,897 $ 20,853 $ 20,405 $ 20,247
Operating Earnings                 3,185 2,867 2,599
Depreciation                 803 871 918
Additions to Long-term Assets                 1,366 1,354 5,290
Total Assets 52,666       41,247       52,666 41,247 41,207
Other                      
Segment and Geographical Area Information                      
Net Sales to External Customers                 2,386 2,272 2,469
Depreciation                 236 247 275
Additions to Long-term Assets                 582 747 4,603
Total Reportable Segments                      
Segment and Geographical Area Information                      
Net Sales to External Customers                 18,467 18,133 17,778
Operating Earnings                 4,614 4,631 4,253
Depreciation                 567 624 643
Additions to Long-term Assets                 784 607 687
Total Assets 10,045       9,777       10,045 9,777 10,172
Total Reportable Segments | Established Pharmaceutical Products                      
Segment and Geographical Area Information                      
Net Sales to External Customers                 3,859 3,720 3,118
Operating Earnings                 723 658 624
Depreciation                 71 83 72
Additions to Long-term Assets                 161 112 136
Total Assets 2,486       2,210       2,486 2,210 2,244
Total Reportable Segments | Nutritional Products                      
Segment and Geographical Area Information                      
Net Sales to External Customers                 6,899 6,975 6,953
Operating Earnings                 1,660 1,741 1,459
Depreciation                 160 157 173
Additions to Long-term Assets                 207 142 174
Total Assets 3,189       3,187       3,189 3,187 3,435
Total Reportable Segments | Diagnostic Products                      
Segment and Geographical Area Information                      
Net Sales to External Customers                 4,813 4,646 4,721
Operating Earnings                 1,194 1,171 1,079
Depreciation                 267 310 314
Additions to Long-term Assets                 392 321 349
Total Assets 2,945       2,844       2,945 2,844 2,964
Total Reportable Segments | Vascular Products                      
Segment and Geographical Area Information                      
Net Sales to External Customers                 2,896 2,792 2,986
Operating Earnings                 1,037 1,061 1,091
Depreciation                 69 74 84
Additions to Long-term Assets                 24 32 28
Total Assets $ 1,425       $ 1,536       $ 1,425 $ 1,536 $ 1,529